{
  "title": "Special Episode: Is Herd Immunity Even Possible?",
  "description": "<p>Amid declining rates of vaccinations in the U.S, virus mutations and a crisis in India, is herd immunity from COVID-19 still achievable? The latest insights from Biotech equity analyst, Matthew Harrison.</p>",
  "itunes:title": "Special Episode: Is Herd Immunity Even Possible?",
  "itunes:episodeType": "full",
  "itunes:episode": 359,
  "itunes:summary": "Amid declining rates of vaccinations in the U.S, virus mutations and a crisis in India, is herd immunity from COVID-19 still achievable? The latest insights from Biotech equity analyst, Matthew Harrison.",
  "content:encoded": "<p>Amid declining rates of vaccinations in the U.S, virus mutations and a crisis in India, is herd immunity from COVID-19 still achievable? The latest insights from Biotech equity analyst, Matthew Harrison.</p>",
  "guid": "gid://art19-episode-locator/V0/0Wrc2ImbsB3U3pUl9DxihMpl071hcXPYpX7-1dJ1GLY",
  "pubDate": "Thu, 06 May 2021 22:14:23 -0000",
  "itunes:explicit": "no",
  "itunes:image": "",
  "itunes:duration": "00:11:41",
  "enclosure": ""
}